A randomised Parallel Group, Active Comparator controlled multicentre study to evaluate the efficacy and safety of G17DT in

  • Parks, Rowan (Principal Investigator)
  • Jodrell, Duncan (Co-investigator)

Project Details

StatusFinished
Effective start/end date1/04/01 → 30/03/04

Funding

  • UK industry, commerce and public corporations: £10,500.00